Dihydroergotamine

What is Dihydroergotamine?

Dihydroergotamine (DHE) is a semi-synthetic derivative of ergotamine, belonging to the class of medications known as ergot alkaloids. It is primarily used for the acute treatment of moderate to severe migraine attacks and cluster headaches. Unlike some other migraine medications, DHE is effective even when administered later in a migraine attack, making it a valuable option for many patients.

First introduced in the mid-20th century, DHE has a long history of use in neurology. It works by affecting specific receptors in the brain and blood vessels, helping to alleviate the severe pain and associated symptoms of these debilitating headaches. Available in various forms, including injectable solutions (intravenous, intramuscular, subcutaneous) and nasal sprays, Dihydroergotamine offers flexibility in administration, allowing healthcare providers to tailor treatment to individual patient needs.

It is important to note that Dihydroergotamine is an abortive treatment, meaning it is designed to stop a headache once it has started, rather than to prevent headaches from occurring. It is not typically used for tension headaches or other types of pain.

How Does it Work?

The mechanism of action of Dihydroergotamine is complex but primarily involves its interaction with serotonin (5-HT) receptors, particularly the 5-HT1B and 5-HT1D subtypes. DHE acts as a partial agonist at these receptors, which are found on both cranial blood vessels and nerve endings.

• Vasoconstriction: By stimulating 5-HT1B receptors on the smooth muscle cells of cranial blood vessels, Dihydroergotamine causes vasoconstriction. During a migraine attack, these blood vessels often dilate, contributing to the throbbing pain. DHE helps to constrict them back to a more normal state.
• Neurogenic Inflammation Inhibition: DHE also acts on 5-HT1D receptors located on presynaptic nerve terminals. This action inhibits the release of neuropeptides, such as calcitonin gene-related peptide (CGRP), which are involved in neurogenic inflammation and pain transmission during a migraine attack.

Furthermore, Dihydroergotamine has some affinity for alpha-adrenergic and dopamine receptors, which may contribute to its overall therapeutic effects and side effect profile. Its broad receptor binding profile distinguishes it from triptans, which are more selective for 5-HT1B/1D receptors.

Medical Uses

Dihydroergotamine is a critical medication in the acute management of severe headache disorders. Its primary medical uses include:

• Acute Migraine Treatment

  DHE is highly effective for the acute treatment of moderate to severe migraine attacks, particularly those that have not responded well to other abortive therapies like NSAIDs or triptans. It can be particularly useful for migraines with prolonged auras or those that are refractory to standard treatments. Its efficacy is recognized for both migraine with and without aura.

• Acute Cluster Headache Treatment

  For patients suffering from cluster headaches, Dihydroergotamine can provide significant relief during an acute attack. While oxygen and triptans are often first-line, DHE is a valuable alternative, especially in cases where other treatments are contraindicated or ineffective. It helps to reduce the intensity and duration of these extremely painful headaches.

It is crucial to understand that Dihydroergotamine is not intended for the prophylactic (preventive) treatment of migraines or cluster headaches. It should only be used to treat an attack once it has begun.

Dosage

The dosage of Dihydroergotamine varies significantly based on the route of administration, the specific condition being treated, and individual patient factors. It is imperative to always follow a healthcare professional's prescription and guidance.

• Intranasal Spray

  Typically, 1 spray (containing 0.5 mg DHE) is administered into each nostril, for a total dose of 1 mg. This dose may be repeated after 15-60 minutes, with a maximum of 4 sprays (2 mg) in a 24-hour period and no more than 6 sprays (3 mg) in a 7-day period. The nasal spray form is often preferred for its ease of use and rapid absorption.

• Injectable (Intravenous, Intramuscular, Subcutaneous)

  Injections are often used in hospital settings or for patients with severe, intractable headaches. Common doses range from 0.5 mg to 1 mg, which can be repeated. The maximum daily dose for injectable forms generally does not exceed 3 mg, and the weekly maximum is usually 6 mg. Intravenous administration often provides the fastest relief.

Overuse of Dihydroergotamine can lead to medication overuse headache (MOH), also known as rebound headache. Patients should be educated on the importance of adhering to prescribed limits to avoid this complication.

Side Effects

Like all medications, Dihydroergotamine can cause side effects. These can range from mild to severe, and it's important for patients to be aware of them. Common side effects include:

• Nausea and vomiting (very common, often managed with antiemetics)
• Dizziness or lightheadedness
• Diarrhea
• Abdominal pain or cramps
• Muscle cramps or stiffness
• Numbness or tingling in fingers and toes

More serious, though less common, side effects require immediate medical attention:

• Ergotism: A severe condition characterized by intense vasoconstriction, leading to peripheral ischemia (reduced blood flow to extremities), which can manifest as cold, pale, or bluish fingers and toes, severe pain, and in rare cases, gangrene.
• Chest pain, tightness, or pressure (can mimic heart attack symptoms)
• Changes in heart rate or rhythm
• High blood pressure
• Severe allergic reactions (rash, itching, swelling, severe dizziness, trouble breathing)

Contraindications: Dihydroergotamine is contraindicated in patients with coronary artery disease, peripheral vascular disease, uncontrolled hypertension, severe liver or kidney impairment, sepsis, and during pregnancy or breastfeeding. It should also not be used within 24 hours of taking a triptan or other ergotamine-containing medications.

Drug Interactions

Several drug interactions can increase the risk of serious side effects when taking Dihydroergotamine. It's crucial to inform your doctor about all medications, supplements, and herbal products you are taking.

• CYP3A4 Inhibitors

  Potent inhibitors of the cytochrome P450 3A4 enzyme can significantly increase DHE levels in the blood, leading to an elevated risk of ergotism. Examples include macrolide antibiotics (e.g., erythromycin, clarithromycin), protease inhibitors (e.g., ritonavir, nelfinavir), and some antifungal agents (e.g., ketoconazole, itraconazole). Concomitant use is contraindicated.

• Triptans

  Using Dihydroergotamine within 24 hours of taking another serotonin 5-HT1 agonist (triptans like sumatriptan, zolmitriptan) is contraindicated due to the increased risk of prolonged vasoconstriction and ischemic reactions.

• Beta-Blockers

  Concurrent use with beta-blockers may increase the risk of peripheral vasoconstriction.

• Nicotine

  Smoking or using nicotine replacement products can also increase the risk of vasoconstriction.

• Other Vasoconstrictors

  Avoid co-administration with other vasoconstrictive agents, including sympathomimetics, due to additive effects.

FAQ

• Is Dihydroergotamine addictive?

  While not considered addictive in the traditional sense, overuse of Dihydroergotamine can lead to medication overuse headaches (MOH), where stopping the medication can trigger withdrawal-like symptoms and rebound headaches. It should be used sparingly and under medical supervision.

• How quickly does Dihydroergotamine work?

  The onset of action varies by administration route. Intravenous DHE can work within minutes, while intramuscular or subcutaneous injections typically take 15-30 minutes. Nasal sprays usually begin to provide relief within 30-60 minutes.

• Can Dihydroergotamine prevent migraines?

  No, Dihydroergotamine is an abortive medication, meaning it is used to treat a migraine or cluster headache attack once it has started. It is not effective for preventing headaches.

• What is ergotism?

  Ergotism is a serious condition caused by excessive ergot alkaloid exposure. It manifests as intense, prolonged vasoconstriction, leading to symptoms like cold, numb, or painful extremities, and in severe cases, gangrene. It can also affect the heart and brain.

• Who should not take Dihydroergotamine?

  Individuals with uncontrolled high blood pressure, heart disease (including angina or history of heart attack), peripheral vascular disease, severe kidney or liver disease, sepsis, or those who are pregnant or breastfeeding should not take Dihydroergotamine. It is also contraindicated with certain medications, particularly strong CYP3A4 inhibitors.

Products containing Dihydroergotamine are available through trusted online pharmacies. You can browse Dihydroergotamine-based medications at ShipperVIP or Medicenter.

Summary

Dihydroergotamine is a well-established and effective medication for the acute treatment of moderate to severe migraine and cluster headaches. As an ergot alkaloid, it works by causing vasoconstriction of cranial blood vessels and inhibiting neurogenic inflammation through its action on serotonin receptors. Available in injectable and nasal spray forms, it offers flexibility for patients who require rapid and reliable relief.

While generally safe when used appropriately, Dihydroergotamine carries risks of side effects, including common gastrointestinal upset and more serious concerns like ergotism, particularly with overuse or certain drug interactions. Careful adherence to prescribed dosages and awareness of contraindications are crucial. Patients should always consult their healthcare provider to determine if Dihydroergotamine is the right treatment option for their specific condition and to understand its proper use.